Crescent Biopharma(CBIO.US)

Last Updated 19:00:00 ET
longbridge loading

Crescent Biopharma Announces Grants of Inducement Awards

Unusual Whales·
US
CBIO
-0.38%
Unusual Whales·
US
CBIO
-0.38%

Crescita Reports First Quarter 2026 Results | CRRTF Stock News

StockTitan·
US
CBIO
-0.38%
StockTitan·
US
CBIO
-0.38%

Crescent Biopharma | 10-Q: FY2026 Q1 Revenue: USD 22.52 M

Earnings Watch·
US
CBIO
-0.38%
Earnings Watch·
US
CBIO
-0.38%

Crescent Biopharma | 8-K: FY2026 Q1 Revenue: USD 22.52 M

Earnings Watch·
US
CBIO
-0.38%
Earnings Watch·
US
CBIO
-0.38%

Stifel Nicolaus Keeps Their Buy Rating on Crescent Biopharma (CBIO)

Tip Ranks·
US
CBIO
-0.38%
Tip Ranks·
US
CBIO
-0.38%

08:00 ETCGBIO Receives FDA 510(k) Clearance for Patient-Specific Titanium Implant 'EASYMADE TI'

prnewswire·
US
CGEN
-4.55%
US
GBIO
0.00%
US
CBIO
-0.38%
prnewswire·
US
CGEN
-4.55%
US
GBIO
0.00%
US
CBIO
-0.38%

Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings | CRRTF Stock News

StockTitan·
US
CBIO
-0.38%
US
CRSP
-2.00%
US
XLV
+1.10%
StockTitan·
US
CBIO
-0.38%
US
CRSP
-2.00%
US
XLV
+1.10%

Crescita Narrows Losses in 2025 and Agrees to Premium All-Cash Takeover by ClinActiv

Tip Ranks·
US
CBIO
-0.38%
Tip Ranks·
US
CBIO
-0.38%
© 2026 Longbridge｜Disclaimer